关于公司
- 法定名称: Beijing Kawin Technology Share-Holding Co.,Ltd
- 注册国家: China
- 地址: No.6 Rongjing East Street, BDA, Beijing, China, Beijing
- 员工人数: 500 - 999
描述:
Focused on viral and immune diseases, Kawin offers mature products built on its specialty in interferon strain management to EP standards, and provides product licensing opportunities including a portfolio of glycyrrhizin products used in dermatology and hepatology, with transfer of interferon and G-CSF (both conventional and pegylated) open to discussion.
业务活动
生物制药产品
原料药生产商
生物制药服务
原料药生产商
ATC(解剖学-治疗学-化学)分类系统
原料药生产商
销售市场
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain
我们的产品与服务
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论